Equities

Medrx Co Ltd

4586:TYO

Medrx Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)90.00
  • Today's Change-1.00 / -1.10%
  • Shares traded219.00k
  • 1 Year change-47.67%
  • Beta2.2384
Data delayed at least 20 minutes, as of Nov 13 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(930)(1109)(1058)
Depreciation/depletion464660
Non-Cash items1.603.47(5.97)
Cash taxes paid, supplemental2.962.501.50
Cash interest paid, supplemental----1.47
Changes in working capital(31)(14)80
Total cash from operations(914)(1073)(924)
INVESTING
Capital expenditures(0.76)(1.96)(2.54)
Other investing and cash flow items, total------
Total cash from investing(0.76)(1.96)(2.54)
FINANCING
Financing cash flow items1.754.1815
Total cash dividends paid------
Issuance (retirement) of stock, net1,638352851
Issuance (retirement) of debt, net----(50)
Total cash from financing1,639356816
NET CHANGE IN CASH
Foreign exchange effects1.769.321.60
Net change in cash727(710)(109)
Net cash-begin balance/reserved for future use9941,7041,812
Net cash-end balance/reserved for future use1,7219941,704
SUPPLEMENTAL INCOME
Depreciation, supplemental464660
Cash interest paid, supplemental----1.47
Cash taxes paid, supplemental2.962.501.50
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.